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Abstract 
Dissecting the organization of circuit pathways involved in pain affect is pivotal for 
understanding behavior associated with noxious sensory inputs. The central nucleus of amygdala 
(CeA) is comprised of distinct populations of inhibitory GABAergic neurons expressing a wide 
range of molecular markers. CeA circuits are associated with aversive learning and nociceptive 
responses. The CeA receives nociceptive signals directly from the parabrachial nuclei (PBn), 
contributing to the affective and emotional aspects of pain. While the CeA has emerged as an 
important node in pain processing, key questions remain regarding the specific targeting of PBn 
inputs to different CeA subregions and cell types. We used a multifaceted approach involving 
transgenic reporter mice, viral vector-mediated optogenetics, and brain slice electrophysiology to 
delineate cell-type-specific functional organization of the PBn-CeA pathway. Whole-cell patch 
clamp recordings of molecularly defined CeA neurons while optogenetically driving long-range 
inputs originating from PBn revealed the direct monosynaptic excitatory inputs from PBn 
neurons to three major subdivisions of the CeA: laterocapsular (CeC), lateral (CeL) and medial 
(CeM). Direct monosynaptic excitatory inputs from PBn targeted both somatostatin-expressing 
(SOM+) and corticotropin-releasing hormone expressing (CRH+) neurons in CeA. We find that 
monosynaptic PBn input is preferentially organized to molecularly specific neurons in distinct 
subdivisions of the CeA. The spared nerve injury model of neuropathic pain differentially altered 
PBn monosynaptic excitatory input to CeA neurons based on molecular identity and 
topographical location within the CeA. These results provide insight into the functional 
organization of affective pain pathways and how they are altered by chronic pain.  
Key words: Parabrachial nucleus, amygdala, pain, somatostatin, corticotrophin-releasing 
hormone 
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Introduction 
Pain is an unpleasant and multidimensional experience that involves sensorimotor, 
emotional-affective and cognitive components [54; 57]. Somatosensory pain is protective by 
alerting injury and/or threat [4]. However, pathological pain commonly leads to affective 
disorders and cognitive impairment [79; 80]. Despite progress in understanding sensory 
dimensions of pain, mechanisms underlying pain affect, while emerging, remain unresolved. 
Dissecting circuits modulating pain affect is pivotal for understanding the functional 
organization of neural networks mediating pain and for facilitating novel therapeutic strategies 
for chronic pain patients [20].  
Amygdala dysfunction is implicated in many disorders including addiction, autism and 
anxiety disorders [18; 29; 33; 39], but it has also emerged as an important focus in pain research 
[57; 60]. The amygdala contains anatomically and functionally distinct nuclei: the basolateral 
complex, which includes the lateral (LA), basolateral (BL), and basomedial (BM) nuclei; the 
central nucleus (CeA), which can be subdivided into the laterocapsular (CeC), lateral (CeL) and 
medial (CeM) subregions [28; 48; 64]. Sensory information reaches the amygdala mainly 
through the LA, whereas the CeA houses major output pathways for amygdala function [48; 64]. 
The CeA is termed the “nociceptive amygdala” as it receives noxious sensory information from 
the spinal cord and brain stem via the parabrachial nucleus (PBn) [6; 9; 31; 32; 41; 57; 68; 69; 
74]. Inputs from lateral PBn targeting the CeA are primarily excitatory and monosynaptic [58; 
73].  Novel work has also shown that the PBn-CeA pathway transmits aversive signals important 
for threat and avoidance memory [17; 35; 70]. However, the organization of PBn inputs to 
specific neural populations in different CeA subdivisions remains unresolved. 
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In the BLA, a majority (≈ 80%) of neurons are glutamatergic and a minority (≈ 20%) are 
GABAergic [53; 72]. Conversely, the CeA houses distinct GABAergic neuronal populations 
expressing a wide range of molecular markers, including corticotropin-releasing hormone 
(CRH), somatostatin (SOM), protein kinase C-δ (PKC-δ) and neurotensin (Nts) [28; 45; 52]. 
Studies show that CeL-SOM+ neurons are crucial for expression of conditioned fear [49; 62] and 
that CeA-CRH+ neurons are involved in anxiety-like behavior and fear learning [61; 67]. Later 
work suggests that SOM+ and CRH+ neurons in CeL mediate appetitive, but not defensive 
behaviors [45]. However, organization of PB inputs to these cell types, both in naïve and chronic 
pain animals, remains unclear but is crucial for understanding the transition of noxious input to 
behavior.  
Here, we used viral vector-mediated optogenetics and two transgenic Cre reporter mouse 
lines to selectively probe PBn inputs onto SOM+ and CRH+ neurons in distinct CeA subregions 
using whole-cell electrophysiological recordings in slice. These experiments expand on the 
notion that PBn input to the CeA is topographically organized [6; 10; 30; 41; 68] and test the 
hypothesis that PBn input differentially targets CeA neurons based on molecular identity. We 
next tested neuropathic pain-induced alterations to plasticity of PBn-CeA inputs using the spared 
nerve injury model (SNI). Results from our study provide insight into mechanisms of how 
ascending noxious inputs target specific CeA cell-types implicated in various pain-related 
behaviors.  AC
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Methods 
Ethical Approval 
The Institutional Animal Use and Care Committee of the Indiana University School of 
Medicine approved all procedures and experiments presented in this study. Animals were used in 
accordance with the animal care and use guidelines of Indiana University, the National Institutes 
of Health, and the Society for Neuroscience. 
Animals 
The heterozygous SOM-IRES-Cre;Ai14 mice were generated by mating female 
homozygous SOM-IRES-Cre (Jackson laboratory stock no. 013044) mice with male 
homozygous Ai14 (C57BL/6J-congenic version, Allen Institute line Ai14, Jackson Labs no. 
007914) mice. The heterozygous CRH-ires-Cre;Ai14 mice were generated by mating female 
homozygous CRH-ires-Cre (Jackson laboratory stock no. 013044) mice with male homozygous 
Ai14 (C57BL/6J-congenic version, Allen Institute line Ai14, Jackson Labs no. 007914) mice. 
The heterozygous SOM-IRES-Cre;Ai14 or CRH-ires-Cre;Ai14 mice of both sexes were used in 
all experiments. Mice were housed on a 12:12 hour light:dark schedule (lights on at 7:00) with 
ad libitum access to food and water.  
Intracranial injection of pACAGW-ChR2-Venus-AAV into the lateral PBn 
Mice were anesthetized with 1.5% isoflurane in 100% O2 with a flow rate of 0.8 L/min 
(SurgiVet Isotech 4; Smith). The top of the head was shaved. The head was stabilized in a 
stereotaxic frame (900 series, Kopf instruments, Tujunga, CA, USA). Betadine and ethanol were 
applied in alternating fashion 3-4 times to disinfect the shaved area. Body temperature was 
maintained at 37°C using a feedback-controlled heating pad (FHC). For PBn injection, the scalp 
was incised, a craniotomy was made, the dura was reflected, and pipettes were advanced to reach 
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the stereotaxic coordinates of the desired target. The pipette was advanced to the intracranial 
target and a submicroliter volume (100 nL) of pACAGW-ChR2-Venus-AAV (20071-AAV1, 
Addgene, Watertown, MA, USA) was injected at a rate of 25 nL/min using a Hamilton syringe 
connected to an UltraMicoPump 3 driven by a Micro 4 MicroSyringe Pump Controller (World 
Precision Instruments, Sarasota, FL, USA). The pipette was kept in place for 5-7 min to limit 
virus reflux out of the injection site. The incision was closed with tissue adhesive (Vetbond). 
Following surgery, meloxicam (5 mg/kg) was injected subcutaneously for pain relief during 
recovery. Stereotaxic details for PBn injections are as follows: the head was fixed at a 38° down 
angle and coordinates were (relative to lambda): 4.42 mm caudal, 1.15 mm lateral and 3.0 mm 
deep at a 54° angle off the horizontal plane. Targeting of pACAGW-ChR2-Venus-AAV into the 
lateral PBn was verified using a fluorescence stereo microscope (Leica M165 FC) to image slices 
of the PBn. Animals were allowed at least 14 days of recovery and adequate anterograde ChR2-
YFP expression before slice electrophysiology experiments. 
Spared nerve injury model 
Spared nerve injury (SNI) surgeries were performed based on published protocols from 
previous studies [13; 19; 23; 55]. Briefly, mice were anesthetized with 1.5% isoflurane in 100% 
O2 with a flow rate of 0.8 L/min (SurgiVet Isotech 4; Smith). After shaving the left hind leg 
area, an incision was made in the skin overlying the area where the sciatic nerve branches into 3 
peripheral nerves (common peroneal, tibial and sural). The overlying muscles were spread apart 
to obtain access to the trifurcation of the sciatic nerve. Once exposed, the common peroneal and 
the tibial branches of the sciatic nerve were ligated (silk 6-0) and cut, leaving only the sural 
nerve intact. The wound was closed using tissue adhesive (Vetbond). 
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Assessment of pain behavior 
Mice were acclimatized to the pain testing behavior apparatus, behavioral suite and 
experimenter before the von Frey filament paw-withdrawal threshold was established. 
Acclimatization entailed placing the mouse inside a clear 6-inch vertical plastic tube (4-inch 
internal diameter) on top of a wire mesh platform (exposing the hindpaws for testing). Mice were 
acclimatized for two non-consecutive days for 30 min each day prior to recording baseline 
withdrawal thresholds. Baseline withdrawal threshold (for both hindpaws) was established prior 
to the SNI surgery by following the ‘simplified up-down’ or SUDO method [11]. On 
postoperative day 10 (POD-10), the SUDO method was used to assess mechanical allodynia, 
both ipsilateral and contralateral to the injury. Experimenters were blinded to treatment groups 
(sham vs. SNI) during behavioral testing. Using standard von Frey filaments 2–9 (filament 1: 
0.008 g; filament 2: 0.02 g; filament 3: 0.07 g; filament 4: 0.16 g; filament 5: 0.4 g; filament 6: 1 
g; filament 7: 2 g; filament 8: 6 g) testing began with the middle filament (filament 4). The 
pressure from the filament was applied to the lateral aspect of the hind paw for 3 seconds and 
behavior responses such as hind paw retraction, paw licking or shaking were considered as 
nocifensive behavior, and classified as a pain response [51]. If the applied filament did not elicit 
a response the next highest filament was used, while if a response was elicited, the next lowest 
filament was used until the fifth and final filament was presented. This method minimized the 
number of filament presentations to the mouse and maximized score sensitivity. On the day of 
slice experiments, a final withdrawal testing was performed, with the mouse being killed 
immediately thereafter. 
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Acute brain slice preparation 
After brief anesthetization by isoflurane, injected mice were decapitated and brains were 
rapidly extracted (< 1 min) and placed in ice-chilled cutting solution (in mM: 110 choline 
chloride, 25 NaHCO3 (sodium bicarbonate), 25 D-glucose, 11.6 sodium ascorbate, 7 MgSO4 
(magnesium sulfate), 3.1 sodium pyruvate, 2.5 KCl, 1.25 NaH2PO4, and 0.5 CaCl2). Coronal 
slices (300 µm) containing the amygdala were prepared by vibratome (VT1200S, Leica), and 
transferred to artificial cerebrospinal solution (ACSF, in mM: 127 NaCl, 25 NaHCO3, 25 D-
glucose, 2.5 KCl, 1 MgCl2, 2 CaCl2, and 1.25 NaH2PO4, aerated with 95% O2 / 5% CO2) at 37 
°C for 30 min. Slices were subsequently incubated in ACSF at 21-22 °C for at least 45-60 
minutes prior to electrophysiological recordings and optogenetic experiments.  
Optogenetic and electrophysiological recordings 
Briefly, slices were transferred to the recording chamber of a SliceScope Pro 6000 
(Scientifica) containing an upright microscope (BX51, Olympus) and PatchStar 
micromanipulators (Scientifica), and held in place with short pieces of flattened gold wire (0.813 
mm diameter; Alfa Aesar). Fluorescently labeled neurons were visualized using coolLED optics 
(Scientifica) and a Retiga-2000 camera (QImaging). Pipettes for whole-cell recordings were 
fabricated from borosilicate capillaries with filaments (G150-F, Warner) using a horizontal puller 
(P-97, Sutter), and filled with intracellular solution composed of the following (in mM): 128 Cs-
methanesulfonate, 10 HEPES, 1 EGTA, 4 MgCl2, 4 ATP, and 0.4 GTP, 10 phosphocreatine, 3 
ascorbate, and 0.05 AlexaFluor 488 (Molecular Probes), pH 7.3. EGTA was included both to 
facilitate seal formation and to reduce cytosolic calcium elevations induced by the various 
stimulus protocols used in these studies. ACSF was used as the extracellular recording solution. 
Recordings were targeted to tdTomato-expressing CeA neurons 60 – 100 µm deep in the slice. 
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Pipette capacitance was compensated; series resistance was monitored but not compensated, and 
required to be < 35 MΩ for inclusion in the dataset. Recordings were filtered at 4 kHz and 
digitized at 10 kHz. Slices were ideally used 1.5–3 h after preparation, but some were used up to 
6 h after preparation. Recordings were performed at 30–34°C. The recording temperature was 
controlled by an in-line heating system (TC324B, Warner). The ACSF was refreshed every 2 h. 
In voltage clamp configuration, excitatory (glutamatergic) and inhibitory (GABAergic) 
responses during photoactivation of ChR2-positive PBn projections were recorded at command 
voltages of -70 mV (near the GABAergic reversal potential) and +10 mV (near the glutamatergic 
reversal potential), respectively. Wide-field photoactivation (20 msec for recording EPSCs and 
IPSCs, 5 msec for recording paired-pulse ratio (PPR)) of ChR2- positive PBn axons was 
performed using a 470 nm wavelength LED (CoolLED pE excitation system) in line with a GFP 
filter (ET FITC/GFP, Olympus) and a 4X objective. For isolating monosynaptic inputs, 
tetrodotoxin (TTX, 1 µM) and 4-aminopyridine (4-AP, 100 µM) were added to the bath solution 
(ACSF) at least 5 minutes before starting to record. The application of this strategy is because 
that the TTX abolishes action potentials and thus eliminates polysynaptic transmission relying on 
action potential propagation, and 4-AP blocks potassium channels and enhances local 
depolarization of photostimulated ChR2-expressing axons, which results in local photoevoked 
depolarization of presynaptic terminals sufficient to induce neurotransmitter release [63; 77]. 
This approach was applied in all experiments. Comparisons of monosynaptic strength were done 
using sequential recordings of adjacent neurons within the same brain slice and CeA subregion to 
limit variability due to AAV infection variability and/or slice orientation. The order of recorded 
neurons was alternated between paired neurons at similar depths within the slice. To evaluate the 
SNI-induced changes to synaptic plasticity in the PBn-CeA pathway, we used a paired-pulse 
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stimulation (100 msec between pulses) protocol using light to evoke transmission. The paired 
pulse ratio (PPR) is the ratio of the amplitude of the second EPSC to that of the first, reflecting 
presynaptic release probability; a lower PPR correlates with higher release probability [49]. 
Statistical analysis 
Custom MATLAB (Mathworks, Natick, MA, USA) routines were used to analyze the 
data off-line. A two-way ANOVA was conducted to determine the effects of the SNI model on 
mechanical allodynia using Prism (GraphPad Software, San Diego, CA). For all data, a Lilliefors 
test was performed prior to significance testing to determine if the data were normally 
distributed. Comparative analyses for sequential recordings of neuron pairs were performed 
using the Wilcoxon Signed-Rank test. W-values represent the test statistic for the Wilcoxon 
Signed-Rank test. Pairwise comparisons before and after drug application were performed using 
the Student’s paired t-test. Statistical comparisons between sham and SNI groups were 
performed using the Student’s unpaired t-test for normally distributed data and the Wilcoxin 
rank-sum test for non-normally distributed data. Data are represented as means ± SEM. 
Significance was set at p < 0.05, but p-values less than 0.01 are reported.  
RESULTS 
Topographical expression of PBn axons overlaps with SOM+ and CRH+ CeA neurons. 
To test monosynaptic input from PBn to molecularly defined neurons in distinct 
subregions of CeA, we injected the pACAGW-ChR2-Venus-AAV into the right lateral PBn of 
mice transgenically expressing TdTomato red fluorescent protein in SOM+ neurons (Figure 1A-
C). At least two weeks after the viral delivery, acute slices containing the right CeA were 
prepared (Figure 1D, E). The expression of SOM+ neurons was detected throughout CeA with 
strong expression in CeL (Figure 1F, G). Sparse expression of SOM+ neurons was detected in 
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LA/BLA as previously shown [47]. We find YFP-labeled PBn axons throughout the CeA with 
the strongest expression in CeC (Figure 1H, I). However, we did not detect YFP expression in 
LA/BLA (Figure 1H). This pattern of PBn axon terminals in CeA is consistent with previous 
reports [27; 35; 70]. We implemented the same injection strategy in mice transgenically 
expressing TdTomato red fluorescent protein in CRH+ neurons (Figure 1J-L). In acute slices 
containing the CeA, robust expression of CRH+ neurons was detected within CeL with weaker 
expression in CeM and scarce expression in the CeC (Figure 1M-P). CRH+ neurons were also 
detected in the LA/BLA (Figure 1P). The pattern of PBn axon terminals in CRH-tdTomato mice 
was consistent with SOM-tdTomato mice (Figure 1Q-R). This topographic expression for 
SOM+ and CRH+ CeA neurons is consistent with previous studies [45; 52]. Our approach here 
allowed us to target molecularly defined SOM+ and CRH+ neurons in the right CeA for whole-
cell recordings while optogenetically driving long-range synaptic inputs originating in PBn. We 
chose to target the right CeA based on compelling evidence for amygdalar lateralization in 
nociception [14; 15; 42; 66]. 
Parabrachial input differentially targets SOM+ and SOM- neurons in specific subregions 
of CeA  
We first targeted the LA/BLA neurons as negative control for our optogenetic strategy. 
Wide-field photoactivation of ChR2+ PBn axons with 470 nm blue LED light did not evoke any 
monosynaptic EPSCs nor IPSCs (Figure 2A, B) in 9 BLA and 2 LA neurons, which is consistent 
with our anatomical results showing no YFP-labeled PBn axons in the LA/BLA region (Figure 
1). Next, we targeted six CeA neurons (1 SOM+, 1 SOM-, 1 CRH+, 3 CRH- neurons) to 
measure monosynaptic EPSCs and IPSCs (Figure 2C, D). Because NMDA receptors at resting 
membrane potential are completely blocked by Mg2+ [26; 44], the EPSCs measured in our 
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condition (1 mM Mg in ACSF and -70 mV holding membrane potential) were mediated by 
AMPA receptors. We observed light-evoked monosynaptic EPSCs in all 6 CeA neurons 
recorded, and 10 µM NBQX, an AMPA receptor antagonist, blocked the excitatory postsynaptic 
response in all 6 recorded neurons (t(5) = 2.51; p = 0.05; paired t-test; Figure 2D), confirming 
that the light-evoked EPSCs are AMPA-mediated.  
Our recordings revealed that wide-field photoactivation of ChR2+ PBn axons with 470 
nm blue LED light elicited monosynaptic EPSCs in both SOM+ and SOM- neurons recorded 
from all distinct subregions (CeC, CeL and CeM) of CeA (Figure 3). Pairs of SOM+ and SOM- 
CeA neurons at approximately the same depth were sequentially recorded within the same brain 
slice and CeA subregion to normalize for AAV infection variability and/or slice orientation (see 
Methods). We found no statistical difference between amplitude and paired-pulse ratio (PPR) of 
evoked EPSCs from recorded SOM+ (Amplitude: 100 ± 23 pA; PPR: 0.41 ± 0.04) and SOM- 
(Amplitude: 127 ± 38 pA; PPR: 0.41 ± 0.04) neurons in CeL (Amplitude: W = 33; p = 1; PPR: 
W = 31; p = 0.9, Wilcoxon Signed-Rank test; Figure 3A-C). In the CeC, amplitude of 
monosynaptic EPSCs in the SOM- neurons (325 ± 104 pA) was significantly larger than SOM+ 
neurons (74 ± 9.5 pA; W = 13; p = 0.01, Wilcoxon Signed-Rank test) while analysis of PPR 
showed no significant differences (SOM-: 0.39 ± 0.06; SOM+: 0.48 ± 0.05; W = 35; p = 0.3, 
Wilcoxon Signed-Rank test; Figure 3D-F). We detected light-evoked monosynaptic EPSCs in 
12 out of 13 SOM+ and 8 out of 13 SOM- CeM neurons recorded in the CeM.  Amplitude of 
monosynaptic EPSCs in the SOM+ CeM neurons (175 ± 53 pA) was significantly larger than 
EPSCs recorded in SOM- CeM neurons (64 ± 59 pA; W = 14; p = 0.03, Wilcoxon Signed-Rank 
test; Figure 3G, H), but PPR was not significantly different (SOM-: 0.49 ± 0.04; SOM+: 0.40 ± 
0.06; W = 9; p = 0.13, Wilcoxon Signed-Rank test; Figure 3I). These data suggest that 
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efficiency of presynaptic glutamate release from PBn inputs does not account for differences in 
EPSC amplitude between SOM+ and SOM- neurons in CeL and CeM. For all PPR recordings, 
amplitude of monosynaptic EPSCs elicited by the second light pulse was smaller than the first 
light pulse indicating high release probability for PBn synapses targeting CeA neurons. 
We used the same approach to test the organizational principle for monosynaptic inputs 
from the PBn to the CeA in the CRH-tdTomato mice. Our results showed that wide-field 
photoactivation of ChR2+ PBn axons elicits monosynaptic EPSCs in subsets of CRH+ and CRH- 
neurons recorded CeL and CeM (Figure 4). We did not detect expression of CRH+ neurons in 
CeC. We did not find any statistical differences in EPSC amplitude or PPR between CRH+ 
(Amplitude: 61.5 ± 16 pA; PPR: 0.30 ± 0.06) and CRH- (Amplitude: 92.1 ± 33 pA; PPR: 0.42 ± 
0.07) neurons in the CeL (Amplitude: W = 33; p = 0.68; PPR: W = 7; p = 0.07, Wilcoxon 
Signed-Rank test; Figure 4A-C).  Only 4 out of 8 CRH+ neurons and 5 out of 8 CRH- neurons 
recorded in the CeM exhibited EPSCs following stimulation of PBn inputs. As in the CeL, we 
did not find significant differences in EPSC amplitude or PPR between CRH+ (Amplitude: 61.5 
± 16 pA; PPR: 0.30 ± 0.06) and CRH- (Amplitude: 92.1 ± 33 pA; PPR: 0.42 ± 0.07) in CeM 
(Amplitude: W = 7; p = 0.3, Wilcoxon Signed-Rank test; PPR: t(7) = -0.30; p = 0.77, Student’s 
unpaired t-test; Figure 4G, H). 
Spared nerve injury differentially alters presynaptic release probability of parabrachial 
monosynaptic excitatory input to the SOM+ and SOM- neurons in distinct subregions of 
the CeA  
We next tested whether the spared nerve injury (SNI) model of neuropathic pain alters 
the dynamics of PBn input to SOM+ and SOM- CeA neurons. We first injected the pACAGW-
ChR2-Venus-AAV into the lateral PBn of SOM-ires-Cre;A14 mice (Figure 5A). Following 
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adequate recovery time (at least 4 days), the common peroneal and tibial nerve were cut, leaving 
the sural intact to establish the SNI pain model (Figure 5B). Pain behavior was evaluated by 
applying the von Frey fiber to the lateral aspect of the hind paw (Figure 5C). Mice undergoing 
the SNI surgery displayed mechanical hypersensitivity 10 days after the surgery compared to the 
sham mice (50% gram threshold: SNI = 0.003 ± 0.002 g; sham = 1.3 ± 0.46 g; Two-way 
ANOVA; F1,9 = 6.3, p = 0.023, Figure 5D). In brain slices made after behavioral testing, we 
stimulated PBn ChR2+ axons while recording from SOM+ and SOM- neurons in distinct CeA 
subregions (Figure 5E). Our results reveal that SNI significantly increased PPR of PBn input to 
CeC SOM+ neurons when compared to sham mice (SNI: 0.56 ± 0.05; sham: 0.33 ± 0.05; t(10) = 
-2.43; p = 0.035, Student’s unpaired t-test, Figure 5F). Conversely, SNI significantly reduces
PPR of PBn input to CeC SOM- neurons (SNI: 0.25 ± 0.04; sham: 0.54 ± 0.06; t(11) = 3.79; p = 
0.003, Student’s unpaired t-test, Figure 5G). Recordings in CeL show that SNI does not alter 
PPR input to SOM+ (SNI: 0.46 ± 0.07; sham: 0.42 ± 0.06; t(11) = -0.415; p = 0.69, Student’s 
unpaired t-test, Figure 5H) nor SOM- neurons (SNI: 0.47 ± 0.06; sham: 0.52 ± 0.09; t(8) = 
0.461; p = 0.66, Student’s unpaired t-test, Figure 5I). In CeM, our analyses showed that SNI did 
not alter PPR of PBn input to SOM+ neurons (SNI: 0.41 ± 0.1; sham: 0.41 ± 0.09; t(11) = 0.024; 
p = 0.98, Student’s unpaired t-test, Figure 5J), but increased PPR of PBn input to SOM- neurons 
(SNI: 0.64 ± 0.11; sham: 0.31 ± 0.03; t(11) = -2.88; *p = 0.015, Student’s unpaired t-test, Figure 
5K). These results suggest that SNI attenuates synaptic efficacy of PBn input to CeC-SOM+ and 
CeM-SOM- neurons while increasing synaptic efficacy of PBn input to CeC-SOM- neurons.   AC
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Spared nerve injury decreased the presynaptic release probability of parabrachial 
monosynaptic excitatory input to the CRH+ and CRH- CeL neurons  
      We next ran a set of experiments to test effects of SNI on PBn-CeA connections in CRH-
ires-Cre;A14 mice (Figure 6). Consistent with SOM-ires-Cre;A14 mice, CRH-ires-Cre;A14 
mice displayed mechanical hypersensitivity 10 days after SNI (50% gram threshold: SNI = 0.006 
± 0.002 g; sham = 0.7 ± 0.19 g; Repeated measures ANOVA; F1,7 = 10.35, *p = 0.015; Figure 
6A). We targeted CRH+ and CRH- neurons in distinct subregions of CeA for whole-cell patch 
clamp recording while optogenetically stimulating ChR2+ PBn axons (Figure 6B). Our results 
reveal that SNI significantly increases PPR of PBn inputs to both CeL CRH+ (SNI: 0.48 ± 0.05; 
sham: 0.26 ± 0.05; t(10) = -2.85; *p = 0.017, Student’s unpaired t-test; Figure 6C) and CeL 
CRH- neurons (SNI: 0.51 ± 0.05; sham: 0.33 ± 0.02; t(25) = -2.96; **p = 0.007, Student’s 
unpaired t-test; Figure 6D). However, SNI significantly reduces PPR of PBn input to CeM 
CRH+ neurons (SNI: 0.26 ± 0.03; sham: 0.37 ± 0.02; t(11) = 3.00; *p = 0.012, Student’s 
unpaired t-test; Figure 6E). We did not observe any change of PPR in CeM CRH- neurons (SNI: 
0.53 ± 0.07; sham: 0.48 ± 0.07; t(11) = 3.00; p = 0.69, Student’s unpaired t-test; Figure 6F). 
These results indicate that SNI decreases the synaptic efficacy of PBn inputs targeting to CeL 
CRH+ and CRH- neurons while increasing the synaptic efficacy of PBn inputs targeting the 
CeM CRH+ neurons.  
DISCUSSION 
      Accumulated anatomical and physiological evidence clearly demonstrates a PBn-CeA 
circuit that plays an essential role in the emotional-affective dimension of pain [5-8; 10; 32; 35; 
57; 59; 68; 69; 76]. Excitatory synapses from PB to CeA neurons are potentiated in arthritic, 
visceral, neuropathic, inflammatory, and muscle pain models [34; 38; 56; 57; 59; 71; 76] and 
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following nociceptive stimuli with no ongoing injury [46]. These previous studies focused 
mainly on PBn-CeC pathways leading to the labeling of the CeC as the nociceptive-specific sub-
nuclei of the CeA [12; 58; 60].  However, other reports demonstrate that the PBn-CeL pathway is 
also involved in nociceptive transmission [10; 25; 40]. A recent study reveals that CeL neurons 
expressing the calcitonin gene-related peptide receptor (CGRPR) play a key role in consolidating 
PBn input into threat memory [35], uncovering a molecularly specific affective pain circuit 
within the PBn-CeL pathway.  
Here, we expand upon these findings by revealing that PBn differentially targets neurons 
in the CeA based on both molecular identity and topographical location within CeA.  While PBn 
innervation of CeL and CeC subdivisions is well established, we show that PBn inputs to SOM- 
neurons are stronger compared to SOM+ neurons in the CeC.  It is likely that CeC SOM- 
neurons express protein kinase C-δ (PKC-δ) based on work showing that non-overlapping PKC-
δ+ and SOM+ neurons constitute 80-90% of the entire CeL/C population [36; 37; 49; 52]. This is 
consistent with a recent study showing greater density of CGRP+ terminals surrounding PKC-δ+ 
neurons compared to SOM+ neurons in CeL/C [78]. Pivotal work shows that PKC-δ+ neurons 
inhibit CeM output to the periaqueductal gray (PAG) [36; 49]. The PAG is a midbrain structure 
that integrates motivational/limbic and sensory input, including pain, to initiate specific outputs 
including coping behavior [2; 3; 16; 22]. Therefore, our data suggest PBn-CeC circuits 
preferentially and indirectly influence PAG activity, which is relevant for behavioral responses 
to pain input. In CeM, we show that PBn inputs to SOM+ neurons are stronger compared to 
SOM- neurons. While CeM projections to PAG are known [36; 49; 50], molecular profiles of 
these CeM-PAG neurons remain unknown. A subset of PAG-projecting neurons in CeL are 
SOM+ [62], but further work is needed to confirm if this is also true in CeM. Nonetheless, this 
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imbalanced targeting of PBn inputs suggests that SOM+ neurons play a significant role in the 
PBn-CeM pathway.   
We find no differential targeting nor differences in synaptic efficacy of PBn input to 
CRH+ versus CRH- neurons in either CeL or CeM. However, probability of detecting EPSCs in 
CRH+ and CRH- neurons in CeL was less than observed in SOM+ and SOM- neurons. This 
suggests there is a small subset of CeL neurons that do not receive direct input from PBn. Only 
half of the CeM-CRH+ neurons produced EPSCs following stimulation of PBn inputs. This is 
considerably less than the probability of evoking EPSCs in CeM-SOM+ neurons, which suggests 
that PBn differentially targets SOM+ neurons versus CRH+ neurons in CeM. Still, current 
limitations of transgenic strategies does not allow us to directly compare PBn inputs to SOM+ 
and CRH+ neurons in CeM, which would give us the proper control for viral efficiency.  
We further find that the SNI model of neuropathic pain both potentiated and attenuated 
the synaptic efficacy of PBn inputs to CeA neurons, as measured by paired-pulse ratio (PPR), 
and that the nature of these contrasting PPR changes is based on both the molecular identity of 
target neurons and topographical location within CeA. Amplitude of EPSCs evoked by 
monosynaptic inputs from PBn to late-firing CeC neurons is potentiated in the formalin model of 
inflammatory pain [73]. One study shows that a majority of late-firing neurons in CeL express 
PKC-δ [36], which suggests that inflammatory pain enhances PBn input to PKC-δ+ neurons in 
CeC. However, this remains unclear due to another study reporting that subpopulations of both 
PKC-δ+ and SOM+ neurons in CeL display a late-firing phenotype [37]. Our data show that SNI 
potentiates synaptic efficacy of PBn inputs targeting CeC SOM- neurons, which are likely PKC-
δ+ neurons [36; 37; 49; 52]. Interestingly, we find PPR of PBn input to CeC SOM+ neurons 
increases after SNI, which implies an attenuated synaptic efficacy. Given the established 
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reciprocal inhibitory relationship between SOM+ and PKC-δ+ neurons [36; 37; 49], our 
observed SNI-induced decrease and increase in PPR of PBn inputs targeting CeC SOM- and CeC 
SOM+ neurons, respectively, suggests that neuropathic pain shifts excitatory balance toward 
PKC-δ+ (i.e. SOM-) neurons. Pivotal work has shown that a substantial number PKC-δ+ neurons 
in caudal CeL/C express the calcitonin gene-related peptide receptor (CGRPR) and that these 
CeL/C CGRPR+ neurons play a critical role in encoding pain input from PBn [35].  Based on 
these findings and our current data, we speculate that SNI evokes a long-lasting and enhanced 
excitatory tone to PKC-δ+/CGRPR+ neurons in CeC involving changes to synaptic plasticity of 
inputs from CGRP+ PBn neurons.  A related study supports this notion by showing that 
knocking out CGRP in mice prevents decreased PPR observed in CeC neurons following 
induction of inflammatory pain [71]. Therefore, it is likely that we are detecting a similar PBn-
CGRP effect on CeC SOM- neurons in our SNI model of neuropathic pain.  
Surprisingly, we did not detect SNI-induced changes to PPR of PBn input to either CeL-
SOM+ or CeL-SOM- neurons.  This shows that SNI not only evokes changes to topographically 
distinct PBn-CeA pathways (i.e. PBn-CeC), but also induces contrasting changes to synaptic 
efficacy of PBn inputs based on the molecular identity of CeC neurons (i.e. SOM+ vs. SOM-). 
We found that SNI significantly decreases synaptic efficacy of PBn inputs targeting CeM SOM- 
neurons. Functions corresponding to specific molecular markers in the CeM are not well defined. 
Therefore, the functional significance of PPR changes to the PBn-CeM SOM- pathway following 
SNI is inconclusive. Nonetheless, the CeM is the major output of the CeA, and our previous data 
show that a significant subpopulation of CeM neurons send projections throughout multiple 
regions of the PAG [50] suggesting SNI may affect pain-related behaviors via a PBn-CeM-PAG 
pathway.  
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In the CeA, CRH+ neurons modulate fear- and anxiety-like behavior [1; 24; 61; 67] as 
well as negative effects of alcohol withdrawal [21]. We find that SNI reduced synaptic efficacy 
to both CRH+ and CRH- neurons in CeL, which contrasts our data showing no effects of SNI on 
PPR of PBn inputs to SOM+ and SOM- in CeL. One study reports negligible expression of SOM 
and PKC-δ in CeL-CRH+ neurons [67], while others demonstrate substantial (~70%) 
coexpression of SOM in CeL-CRH+ neurons [45; 52]. However, the same studies also reported 
that only 35-50% of CeL-SOM+ neurons express CRH [45; 52], which suggest that we did not 
detect effects of SNI on synaptic efficacy of PBn inputs to CeL-SOM+ neurons because a 
majority we recorded did not coexpress CRH. Why we see reduced synaptic efficacy to CRH- 
neurons in CeL is unclear. It is reported that approximately 19% of CeL neurons are CRH+ [52] 
meaning that the molecular heterogeneity of CeL-CRH- neurons is considerable. Approximately 
90% of CeL neurons are either SOM+ or PKC-δ+, but there are a number of other molecular 
markers that can discriminate between CeL subpopulations including CGRPR, tachykinin 2, 
oxytocin receptor, neurotensin, prodynorphin and dopamine receptor 2 [35; 36; 43; 45; 52]. Our 
data suggest that SNI reduces synaptic efficacy of PBn input to a subpopulation of CeL-CRH- 
neurons that was not represented in our CeL-SOM- recordings. In CeM, we found that SNI 
enhances synaptic efficacy of PBn input to CRH+ neurons.  The CeM contains a large number of 
CRH receptive neurons [67; 75], which likely respond to local release of CRH implicated in 
contextual memory consolidation [65]. Therefore, enhanced PBn input to CeM-CRH+ neurons 
may facilitate memory associated with pain following nerve injury. Whether this enhancement in 
synaptic efficacy happens acutely or over the development of pain behavior induced by SNI 
remains to be elucidated.  
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      In summary, this study is the first to establish an organizational principle of PBn 
monosynaptic input to molecularly defined neurons within the three major subregions of the 
CeA: laterocapsular (CeC), lateral (CeL) and medial (CeM). It further establishes that plasticity 
of distinct PBn-CeA pathways is differentially altered in the SNI model of neuropathic pain. 
Together these findings provide updated insight for dissecting functional changes to CeA circuit 
pathways in pain models as both topography and targeting to neuronal subtypes need to be 
considered.   
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Figure legends 
Figure 1. Co-expression of PBn axons and SOM+ and CRH+ CeA neurons. A, SOM-ires-CRE 
mice were mated with Ai14-LSL-tdTomato reporter mice to obtain SOM-ires-Cre;A14 mice. B, 
Delivery of pACAGW-ChR2-Venus-AAV into the PBn of SOM-ires-Cre;A14 mice. C, A 
representative coronal brain section showing pACAGW-ChR2-Venus-AAV injection into the 
right parabrachial nucleus (PBn) of a SOM-ires-Cre;A14 mouse. D, E, At least two weeks after 
the AAV injection, acute coronal brain slices containing the central amygdala (CeA) were 
prepared. F, Representative bright-field image of slice containing lateral amygdala (LA), 
basolateral amygdala (BLA), and subregions of the CeA (CeC: latero-capsular; CeL: lateral; 
CeM: medial). G, Epifluorescence image showing the expression of SOM+ neurons in the CeA. 
H, Epifluorescence image showing the expression of the PBn axons in the CeA. I, Merged image 
showing the co-expression of tdTomato- expressing SOM+ neurons and Venus-expressing PBn 
axons in the CeA. J, CRH-ires-CRE female mice were mated with Ai14-LSL-tdTomato reporter 
mice to obtain CRH-ires-Cre;A14 mice. K, Delivery of pACAGW-ChR2-Venus-AAV into the 
right PBn of CRH-ires-Cre;A14 mice. L, Coronal brain section showing pACAGW-ChR2-
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Venus-AAV injection into the right PBn from a CRH-ires-Cre;A14 mouse. M, N, At least two 
weeks after the AAV injection, acute coronal brain slices containing the CeA were prepared. O, 
Bright-field image showing a representative acute coronal brain slice containing the CeA. P, 
Epifluorescence image showing the expression of CRH+ neurons in the CeA and LA/BLA. Q, 
Epifluorescence image showing the expression of the PBn axons in the CeA. R, Merged image 
showing the co-expression of CRH+ neurons and PBn axons in the CeA. L: lateral, V: ventral. 
Figure 2. Photoactivation of PBn axon terminals elicited a glutamatergic monosynaptic EPSC in 
the CeA, but not BLA. A, Schematic of wide field stimulation of PBn axons while recording in 
the LA/BLA. B, Photoactivation of PBn axon terminals with blue light did not evoke 
glutamatergic monosynaptic EPSCs (top) nor monosynaptic IPSCs (bottom) in the LA/BLA 
neurons (n = 9; BLA = 7, LA = 2). C, Schematic of wide field stimulation of PBn axons while 
recording in the CeA. D, Photoactivation of PBn axon terminals with blue light evoked 
glutamatergic monosynaptic, AMPA-mediated EPSCs (top), but not IPSCs in CeA neurons 
(bottom). E, The AMPA receptor antagonist NBQX blocked PBn evoked EPSCs in CeA neurons 
(1 SOM+, 1 SOM-, 1 CRH+, 3 CRH- neurons, 4 mice, * p = 0.05).  
Figure 3. Organization of parabrachial monosynaptic excitatory input to SOM+ and SOM- 
neurons in subdivisions of the CeA. A, Schematic recording configuration in CeL of SOM-
tdTomato mice. B, Representative traces of light-evoked (blue ticks) monosynaptic EPSCs (left, 
at -70 mV holding potential, 1 µM TTX + 100 µM 4-AP) and PPR (right, at -70 mV holding 
potential, 1 µM TTX + 100 µM 4-AP; interval 100 msec) in SOM+ (red) and SOM- (black) CeL 
neurons. C, Comparison of monosynaptic EPSCs and paired-pulse ratio (PPR) between SOM+ 
and SOM- CeL neurons (n = 11 pairs/5 mice). D, Schematic recording configuration in CeC. E, 
Representative traces of light-evoked monosynaptic EPSCs and PPR in SOM+ and SOM- CeC 
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neurons. F, Comparison of monosynaptic EPSCs and paired-pulse ratio (PPR) between SOM+ 
and SOM- CeC neurons (n = 14 pairs/5 mice; *p < 0.05). G, Schematic recording configuration 
in CeM. H, Representative traces of light-evoked monosynaptic EPSCs and PPR in SOM+ and 
SOM- CeM neurons. I, Comparison of monosynaptic EPSCs and paired-pulse ratio (PPR) 
between SOM+ (red) and SOM- (black) CeC neurons (n = 14 pairs/5 mice; *p < 0.05). Pairs are 
connected by lines; mean ± S.E.M. of SOM- values (normalized to SOM+ pair) is plotted to the 
right. Comparison of the monosynaptic EPSCs and PPR between SOM+ and SOM- CeM 
neurons (n = 14 EPSC pairs; 9 PPR pairs / 5 mice; *p < 0.05).  
Figure 4. Organization of parabrachial monosynaptic excitatory input to the CRH+ and CRH- 
neurons in subdivisions of the CeA. A, Schematic recording configuration in CeL of CRH-
tdTomato mice. B, Representative traces of light-evoked monosynaptic EPSCs and PPR (interval 
100 msec) recorded from a CRH+ (red) and CRH- (black) CeL neurons. C, Comparison of 
monosynaptic EPSCs (t(11) = -1.05; p = 0.32, Student’s paired t test) and PPR (t(6) = -1.84; p = 
0.11, Student’s paired t test) between CRH+ and CRH- CeL neurons (n = 12 EPSC pairs; 7 PPR 
pairs / 5 mice). D, Schematic recording configuration in CeM of CRH Cre mice. F, 
Representative traces of light-evoked monosynaptic EPSCs and PPR (interval 100 msec) 
recorded from a CRH+ (red) and CRH- (black) CeM neuron. G, Comparison of monosynaptic 
EPSCs (t(7) = -1.23; p = 0.26, Student’s paired t-test) and PPR (CRH+: 4; CRH-: 5; t(7) = -0.30; 
p = 0.77, Student’s unpaired t-test) between CRH+ and CRH- CeM neurons (n = 8 EPSC pairs / 
5 mice).  
Figure 5. SNI distinctly alters PBn input to SOM+ and SOM- neurons based on subdivision of 
CeA. A, Delivery of pACAGW-ChR2-Venus-AAV into the PBn of SOM-ires-Cre;A14 mice. B, 
Schematic of SNI surgery involving transection (grey line) of the tibial and peroneal branches of 
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the sciatic nerve, leaving the sural nerve intact. C, SNI and sham-operated mice were placed in 
cages on an elevated mesh platform for assessment of pain behavior using von Frey filaments. 
The hind paw region innervated by the sural nerve (red) skin was targeted the von Frey hair 
while regions innervated by common peroneal (black) and tibial (grey) nerve were avoided. D, 
50% withdrawal threshold response (mean ± SEM) to von Frey fibers of SNI (n = 5) and sham (n 
= 5) mice (*p = 0.023) on post-operative day 10 (POD-10). E, SOM+ and SOM- CeA neurons 
were sequentially recorded during blue (470 nm) LED wide-field stimulation of ChR2-
expressing PBn axons. F, Representative traces (top) and statistical comparison (bottom) of PPR 
in SOM+ CeC neurons from SNI mice compared to sham mice (SNI: 6 neurons; Sham: 6 
neurons; *p = 0.035). G, Representative traces (top) and statistical comparison (bottom) of PPR 
in SOM- CeC neurons from SNI mice compared to sham mice (SNI: 6 neurons; Sham: 7 
neurons; **p = 0.003). H, Representative traces (top) and statistical comparison (bottom) of PPR 
in SOM+ CeL neurons from SNI and sham mice (SNI: 7 neurons; Sham: 6 neurons; p = 0.69). I, 
Representative traces (top) and statistical comparison (bottom) of PPR in SOM- CeL neurons 
from SNI and sham mice (SNI: 5 neurons; Sham: 5 neurons; p = 0.66). J, Representative traces 
(top) and statistical comparison (bottom) of PPR in SOM+ CeM neurons from SNI mice and 
sham mice (SNI: 6 neurons; Sham: 7 neurons; p = 0.98). K, Representative traces (top) and 
statistical comparison (bottom) of PPR in SOM- CeM neurons from SNI mice compared to sham 
mice (SNI: 6 neurons; Sham: 7 neurons; t(11) = -2.88; *p = 0.015, Student’s unpaired t-test).  
Figure 6. SNI differentially alters PBn input to CRH+ and CRH- neurons in distinct subregions 
of CeA. A, 50% withdrawal threshold response (mean ± SEM) to von Frey fibers of SNI (n = 5) 
and sham (n =4) mice (*p = 0.015) on post-operative day 10 (POD-10). B, CRH+ and CRH- 
CeA neurons were recorded during blue (470 nm) LED wide-field stimulation of ChR2-
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expressing PBn axons. C, Representative traces (top) and statistical comparison (bottom) of PPR 
in CRH+ CeL neurons from SNI compared to sham mice (SNI: 7 neurons; Sham: 5 neurons; *p 
= 0.017). D, Representative traces (top) and statistical comparison (bottom) of PPR in CRH- CeL 
neurons in the SNI mice (SNI: 14 neurons; Sham: 13 neurons; **p = 0.007).  E, Representative 
traces (top) and statistical comparison (bottom) of PPR in CRH+ CeM neurons in SNI compared 
to sham mice (SNI: 5 neurons; Sham: 8 neurons; *p = 0.012). F, Representative traces (top) and 
statistical comparison (bottom) of PPR in CRH- CeM neurons between SNI and sham mice 
(SNI: 9 neurons; Sham: 10 neurons; p = 0.69). 
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